135 related articles for article (PubMed ID: 36991564)
1. IKZF1
Ito Y; Ozawa H; Eto T; Miyamoto T; Kamimura T; Ogawa R; Uchida N; Wake A; Fujisaki T; Ohno Y; Takase K; Okumura H; Takamatsu Y; Kawano N; Akashi K; Nagafuji K
Eur J Haematol; 2023 Jul; 111(1):103-112. PubMed ID: 36991564
[TBL] [Abstract][Full Text] [Related]
2. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
3. Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib.
Sasaki Y; Kantarjian HM; Short NJ; Wang F; Furudate K; Uryu H; Garris R; Jain N; Sasaki K; Ravandi F; Konopleva M; Garcia-Manero G; Little L; Gumbs C; Zhao L; Futreal PA; Takahashi K; Jabbour E
Leukemia; 2022 May; 36(5):1253-1260. PubMed ID: 35132195
[TBL] [Abstract][Full Text] [Related]
4. IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
van der Veer A; Zaliova M; Mottadelli F; De Lorenzo P; Te Kronnie G; Harrison CJ; Cavé H; Trka J; Saha V; Schrappe M; Pieters R; Biondi A; Valsecchi MG; Stanulla M; den Boer ML; Cazzaniga G
Blood; 2014 Mar; 123(11):1691-8. PubMed ID: 24366361
[TBL] [Abstract][Full Text] [Related]
5. Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.
Kim M; Park J; Kim DW; Kim YJ; Jeon YW; Yoon JH; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim HJ; Min CK; Cho SG; Kim Y; Lee JW; Han K; Min WS; Lee S
Bone Marrow Transplant; 2015 Mar; 50(3):354-62. PubMed ID: 25501350
[TBL] [Abstract][Full Text] [Related]
6. Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia.
Mangum DS; Meyer JA; Mason CC; Shams S; Maese LD; Gardiner JD; Downie JM; Pei D; Cheng C; Gleason A; Luo M; Pui CH; Aplenc R; Hunger SP; Loh M; Greaves M; Trede N; Raetz E; Frazer JK; Mullighan CG; Engel ME; Miles RR; Rabin KR; Schiffman JD
JAMA Oncol; 2021 Oct; 7(10):1521-1528. PubMed ID: 34410295
[TBL] [Abstract][Full Text] [Related]
7. COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.
Lopes BA; Meyer C; Barbosa TC; Zur Stadt U; Horstmann M; Venn NC; Heatley S; White DL; Sutton R; Pombo-de-Oliveira MS; Marschalek R; Emerenciano M
Oncotarget; 2016 Aug; 7(33):53064-53073. PubMed ID: 27419633
[TBL] [Abstract][Full Text] [Related]
8. Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients.
Li H; Zhang W; Kuang P; Ye Y; Yang J; Dai Y; Lu X; Zheng Y; Liu T
Leuk Lymphoma; 2018 Aug; 59(8):1890-1898. PubMed ID: 29214878
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of IKZF1
Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
[TBL] [Abstract][Full Text] [Related]
10. IKZF1
Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
[TBL] [Abstract][Full Text] [Related]
11. [Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study].
Chinese Children′s Cancer Group Acute Lymphoblastic Leukemia 2015 Study Group
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1002-1010. PubMed ID: 36207846
[No Abstract] [Full Text] [Related]
12. Prognostic significance of IKZF1 deletions and IKZF1
Braun M; Pastorczak A; Sędek Ł; Taha J; Madzio J; Jatczak-Pawlik I; Wypyszczak K; Matysiak M; Derwich K; Lejman M; Kazanowska B; Szczepański T; Kowalczyk JR; Mlynarski W;
Hematol Oncol; 2022 Aug; 40(3):430-441. PubMed ID: 35118711
[TBL] [Abstract][Full Text] [Related]
13. IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Mitchell RJ; Kirkwood AA; Barretta E; Clifton-Hadley L; Lawrie E; Lee S; Leongamornlert D; Marks DI; McMillan AK; Menne TF; Papaemmanuil E; Patel B; Patrick P; Rowntree CJ; Zareian N; Alapi KZ; Moorman AV; Fielding AK
Blood Adv; 2021 Sep; 5(17):3322-3332. PubMed ID: 34477813
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
[TBL] [Abstract][Full Text] [Related]
15. Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.
Olsson L; Albitar F; Castor A; Behrendtz M; Biloglav A; Paulsson K; Johansson B
Genes Chromosomes Cancer; 2015 May; 54(5):315-25. PubMed ID: 25727050
[TBL] [Abstract][Full Text] [Related]
16. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly.
Vairy S; Tran TH
Blood Rev; 2020 Nov; 44():100677. PubMed ID: 32245541
[TBL] [Abstract][Full Text] [Related]
17. Loss-of-function but not dominant-negative intragenic
Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sugiura I; Doki N; Hata T; Cho R; Ito T; Suehiro Y; Tanaka M; Kako S; Matsuda M; Yokoyama H; Ishikawa Y; Taniguchi Y; Hagihara M; Ozawa Y; Ueda Y; Hirano D; Sakura T; Tsuji M; Kamae T; Fujita H; Hiramoto N; Onoda M; Fujisawa S; Hatta Y; Dobashi N; Nishiwaki S; Atsuta Y; Kobayashi Y; Hayakawa F; Ohtake S; Naoe T; Miyazaki Y
Blood Adv; 2022 Jan; 6(2):624-636. PubMed ID: 34516628
[TBL] [Abstract][Full Text] [Related]
19. [Ikaros family zinc finger 1 mutation is a poor prognostic factor for adult Philadelphia chromosome positive acute lymphoblastic leukemia].
Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Li SY; Cao JJ; Chen LG; Le J; Qian SY; Hong YW; Pei RZ
Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):301-306. PubMed ID: 30917424
[No Abstract] [Full Text] [Related]
20. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]